Overexpression of fatty acid synthase in ulcerative colitis.

Fatty acid synthase is an enzyme that catalyzes the synthesis of long-chain fatty acids. The enzyme expression is minimal in adult tissues and very high in many cancers. Ulcerative colitis is a chronic inflammatory bowel disease that, when long-standing, is associated with an increased risk of colon cancer. The aim of the present study was to establish whether fatty acid synthase levels in the mucosa without dysplasia of patients with long-standing ulcerative colitis were higher than in control subjects. Three groups of patients were selected: 30 with active ulcerative colitis, 30 with ulcerative colitis in remission, and 30 undergoing colonoscopy for colorectal cancer screening, as healthy control subjects. Fatty acid synthase expression was evaluated with immunohistochemical procedures. The enzyme was detected in all patients with active colitis, in most patients with quiescent disease, in both pathologic and normal mucosa, but in only 3 healthy control subjects. Our results suggest that extension of ulcerative colitis is greater than that revealed by common diagnostic techniques.

[1]  D. Heimburger,et al.  The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung. , 2000, Human pathology.

[2]  C. Semenkovich,et al.  Physiologic concentrations of glucose regulate fatty acid synthase activity in HepG2 cells by mediating fatty acid synthase mRNA stability. , 1993, Journal of Biological Chemistry.

[3]  E. Kliewer,et al.  Cancer risk in patients with inflammatory bowel disease , 2001, Cancer.

[4]  J. Winkles,et al.  Fibroblast growth factor-1 induces phosphofructokinase, fatty acid synthase and Ca2+ ATPase mRNA expression in NIH 3T3 cells , 1993 .

[5]  S. Wakil,et al.  Fatty acid synthase, a proficient multifunctional enzyme. , 1989, Biochemistry.

[6]  P. Elias,et al.  Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. , 1992, The Journal of clinical investigation.

[7]  P. Visca,et al.  Fatty acid synthase is a marker of increased risk of recurrence in endometrial carcinoma. , 2004, Gynecologic oncology.

[8]  L. Jacobs,et al.  Fatty acid synthesis: a potential selective target for antineoplastic therapy. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[9]  P. Elias,et al.  Cutaneous permeability barrier disruption increases fatty acid synthetic enzyme activity in the epidermis of hairless mice. , 1995, The Journal of investigative dermatology.

[10]  D. Chalbos,et al.  Fatty acid synthetase and its mRNA are induced by progestins in breast cancer cells. , 1987, The Journal of biological chemistry.

[11]  D. Wang,et al.  Nutritional and hormonal regulation of enzymes in fat synthesis: studies of fatty acid synthase and mitochondrial glycerol-3-phosphate acyltransferase gene transcription. , 1998, Annual review of nutrition.

[12]  M. Kagnoff,et al.  A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. , 1995, The Journal of clinical investigation.

[13]  A. Nashimoto,et al.  Fatty acid synthase is highly expressed in carcinoma, adenoma and in regenerative epithelium and intestinal metaplasia of the stomach , 2002, Histopathology.

[14]  C. Townsend,et al.  Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts. , 2000, Cancer research.

[15]  S. Truelove,et al.  Serial Biopsy in Ulcerative Colitis , 1955, British medical journal.

[16]  T. Sugino,et al.  Fatty acid synthase is expressed mainly in adult hormone-sensitive cells or cells with high lipid metabolism and in proliferating fetal cells. , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[17]  K. Feingold,et al.  Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo. , 1987, The Journal of clinical investigation.

[18]  T. Honjo,et al.  Inhibition of Carnitine Palmitoyltransferase I Augments Sphingolipid Synthesis and Palmitate-induced Apoptosis* , 1997, The Journal of Biological Chemistry.

[19]  F. Marandino,et al.  Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[20]  A. Rashid,et al.  Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. , 1997, The American journal of pathology.

[21]  T. Sugino,et al.  Fatty Acid Synthase Is Expressed Mainly in Adult Hormone-sensitive Cells or Cells with High Lipid Metabolism and in Proliferating Fetal Cells1 , 2000 .

[22]  J. Swinnen,et al.  Stimulation of tumor-associated fatty acid synthase expression by growth factor activation of the sterol regulatory element-binding protein pathway , 2000, Oncogene.

[23]  R. Huganir,et al.  C75, a Fatty Acid Synthase Inhibitor, Modulates AMP-activated Protein Kinase to Alter Neuronal Energy Metabolism* , 2004, Journal of Biological Chemistry.

[24]  R. Kurman,et al.  Fatty acid synthase expression in endometrial carcinoma , 1998, Cancer.

[25]  J. McGarry,et al.  The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. , 1997, European journal of biochemistry.

[26]  J. Kalbfleisch,et al.  Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression of prostate cancer. , 1996, Human pathology.

[27]  P. Visca,et al.  Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients , 1996, Cancer.

[28]  P. Visca,et al.  Fatty acid synthase (FAS) is a marker of increased risk of recurrence in lung carcinoma. , 2004, Anticancer research.

[29]  E. Tsianos,et al.  Risk of cancer in inflammatory bowel disease (IBD). , 2000, European journal of internal medicine.

[30]  C. Townsend,et al.  Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells. , 2003, Cancer research.

[31]  T. Gansler,et al.  Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival. , 1997, Human pathology.

[32]  A W Partin,et al.  OA-519 (fatty acid synthase) as an independent predictor of pathologic state in adenocarcinoma of the prostate. , 1995, Urology.

[33]  Y. Hannun.  Functions of Ceramide in Coordinating Cellular Responses to Stress , 1996, Science.

[34]  Yufang Shi,et al.  The yins and yangs of ceramide , 1999, Cell Research.

[35]  Sumio Watanabe,et al.  Systemic and local evidence of increased Fas-mediated apoptosis in ulcerative colitis , 2002, International Journal of Colorectal Disease.

[36]  S. Piantadosi,et al.  Haptoglobin-related protein (Hpr) epitopes in breast cancer as a predictor of recurrence of the disease. , 1989, The New England journal of medicine.

[37]  P. Morin,et al.  Activation of fatty acid synthesis during neoplastic transformation: role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. , 2002, Experimental cell research.

[38]  J A Winkles,et al.  Fibroblast growth factor-1 induces phosphofructokinase, fatty acid synthase and Ca(2+)-ATPase mRNA expression in NIH 3T3 cells. , 1993, Biochemical and biophysical research communications.